Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline Genetic Testing After Cancer Diagnosis.
Kurian AW, Abrahamse P, Furgal A, Ward KC, Hamilton AS, Hodan R, Tocco R, Liu L, Berek JS, Hoang L, Yussuf A, Susswein L, Esplin ED, Slavin TP, Gomez SL, Hofer TP, Katz SJ. Kurian AW, et al. Among authors: berek js. JAMA. 2023 Jul 3;330(1):43-51. doi: 10.1001/jama.2023.9526. JAMA. 2023. PMID: 37276540 Free PMC article.
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. Berek JS, et al. Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20. Int J Gynaecol Obstet. 2023. PMID: 37337978 Free article.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety.
Matulonis UA, Herrstedt J, Oza A, Mahner S, Redondo A, Berton D, Berek JS, Haslund CA, Marmé F, González-Martín A, Bécourt S, Tinker AV, Ledermann JA, Benigno B, Lindahl G, Colombo N, Malinowska IA, Liu W, Bains M, Monk BJ, Mirza MR. Matulonis UA, et al. Among authors: berek js. Gynecol Oncol. 2025 Apr;195:192-199. doi: 10.1016/j.ygyno.2025.03.018. Epub 2025 Mar 25. Gynecol Oncol. 2025. PMID: 40139026 Clinical Trial.
Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Nahm SH, Kiely BE, O'Connell RL, Lee YC, Davis A, Avall-Lundqvist E, Berek JS, Berton D, Donnellan P, Hilpert F, Joly F, Lanceley A, Ledermann JA, Okamoto A, Oza A, Pignata S, Sehouli J, King MT, Friedlander M, Stockler MR, Roncolato FT; GCIG Symptom Benefit Group. Nahm SH, et al. Among authors: berek js. Int J Gynecol Cancer. 2025 Jan;35(1):100030. doi: 10.1016/j.ijgc.2024.100030. Epub 2024 Dec 18. Int J Gynecol Cancer. 2025. PMID: 39878283
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin N. Matias-Guiu X, et al. Among authors: berek js. Eur J Cancer. 2024 Dec;213:115115. doi: 10.1016/j.ejca.2024.115115. Epub 2024 Nov 5. Eur J Cancer. 2024. PMID: 39520836 Review.
Prevalence and Associated Factors of High-Risk Human Papillomavirus Infections among Human Immunodeficiency Virus-Infected Women in Lagos, Nigeria.
Okunade KS, Badmos KB, Okoro A, Awolola NA, Nwaokorie FO, Adelabu H, Ademuyiwa IY, Adekanye TV, Akhenamen PO, Odoh E, Okoye C, Akanmu AS, Banjo AA, Anorlu RI, Berek JS. Okunade KS, et al. Among authors: berek js. Res Sq [Preprint]. 2024 Jul 19:rs.3.rs-4645178. doi: 10.21203/rs.3.rs-4645178/v1. Res Sq. 2024. PMID: 39070626 Free PMC article. Preprint.
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): Study protocol of a randomised controlled trial.
Okunade KS, Adejimi AA, Adekanye TV, Allsop MJ, Adelabu H, Thomas-Ogodo O, Onyeka TC, Lawanson T, Akaba GO, Salako O, Anorlu RI, Berek JS. Okunade KS, et al. Among authors: berek js. Res Sq [Preprint]. 2024 Jun 27:rs.3.rs-4541493. doi: 10.21203/rs.3.rs-4541493/v1. Res Sq. 2024. Update in: BMC Cancer. 2024 Jun 20;24(1):751. doi: 10.1186/s12885-024-12538-6. PMID: 38978593 Free PMC article. Updated. Preprint.
Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
Okunade KS, Adejimi AA, Adekanye TV, Allsop MJ, Adelabu H, Thomas-Ogodo O, Onyeka TC, Lawanson T, Akaba GO, Salako O, Anorlu RI, Berek JS. Okunade KS, et al. Among authors: berek js. BMC Cancer. 2024 Jun 20;24(1):751. doi: 10.1186/s12885-024-12538-6. BMC Cancer. 2024. PMID: 38902718 Free PMC article.
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
Makker V, Perez-Fidalgo JA, Valabrega G, Hamilton E, Van Gorp T, Sehouli J, Regináčová K, Richardson DL, Perri T, Oza AM, Miller DS, Alía EMG, De Giorgi U, Henry S, Spitz DL, Wimberger P, Bednaříková M, Chon HS, Martínez-Garcia J, Pisano C, Berek JS, Romero I, Scambia G, Fariñas-Madrid L, Buscema J, Schochter F, Li K, Kalyanapu P, Walker CJ, Vergote I. Makker V, et al. Among authors: berek js. Gynecol Oncol. 2024 Jun;185:202-211. doi: 10.1016/j.ygyno.2024.05.016. Epub 2024 Jun 3. Gynecol Oncol. 2024. PMID: 38834399 Free article. Clinical Trial.
312 results